Rowland Lloyd A
- SEC CIK
- 0001236395
No open-market purchases or sales filed in the past year.
Current role at each company
- CTMX CytomX Therapeutics, Inc.General Counselas of Mar 20, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rowland Lloyd A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2025 (view filing) | Mar 18 | 2 days | Rowland Lloyd AGeneral Counsel | SSale | −10.2K | $0.60 | −$6.12K | −7.8%120.6K after | |
| Aug 22, 2024 (view filing) | Aug 20 | 2 days | Rowland Lloyd AGeneral Counsel | SSale | −4.18K | $1.23 | −$5.14K | −3.1%130.8K after | |
| Mar 21, 2024 (view filing) | Mar 19 | 2 days | Rowland Lloyd AGeneral Counsel | SSale | −5.27K | $2.09 | −$11.0K | −4.3%117.7K after | |
| Dec 22, 2023 (view filing) | Dec 20 | 2 days | Rowland Lloyd AGeneral Counsel | SSale | −4.08K | $1.38 | −$5.63K | −4.0%98.0K after | |
| Sep 22, 2023 (view filing) | Sep 22 | Same day | Rowland Lloyd AGeneral Counsel | SSale | −5.49K | $1.30 | −$7.13K | −6.4%80.6K after | |
| Mar 20, 2023 (view filing) | Mar 16 | 4 days | Rowland Lloyd AGeneral Counsel | SSale | −2.04K | $1.98 | −$4.03K | −2.8%71.1K after | |
| Jul 21, 2022 (view filing) | Jul 20 | 1 day | Rowland Lloyd AGeneral Counsel | SSale | −5.60K | $1.42 | −$7.95K | −11.4%43.7K after |